source
- Former Akero executives launch Avere Therapeutics, unveiling China-sourced pipeline drug and reverse merger planThe former leadership team of Akero Therapeutics announced the creation of a new in‑licensing company called Avere Therapeutics. The launch was made public on Tuesday and includes a pipeline drug…
- FDA issues final guidance for psychedelic drug developers and announces public hearingThe FDA has completed a set of clinical guidance documents aimed at companies developing psychedelic medicines. The guidance outlines expectations for trial design, safety monitoring, and data col…